Active Investments

Edge Therapeutics

Private

Ascendis Pharma

Public (NASDAQ: ASND)

Coherus Biosciences

Public (NASDAQ: CHRS)

Impopharma

Private

Zafgen

Private

Intuity Medical

Private

Mevion

Private

QuatRx Pharma

Private

Anacor Pharma

Public (NASDAQ: ANAC)

Alumni Investments

TESARO

Public (NASDAQ: TSRO)

Adnexus

Acquired by Bristol-Myers Squibb

PEAK Surgical

Acquired by Medtronic

Alimera Sciences

Public (NASDAQ: ALIM)

Trubion Pharma

Public (NASDAQ: TRBN)

Anders Hove Partner

Focus Areas: Biotechnology, Medical Devices
Location: New York

Anders Hove has been with Venrock since 2004. His investment activities span biotechnology companies at all stages, from early stage seed to public investments. He currently serves on the Board of Directors of Anacor Pharmaceuticals (NASDAQ: ANAC), as well as several private company Boards, such as Edge Therapeutics, Intuity Medical, QuatRx Pharmaceuticals, Impopharma and Mevion Medical Systems. Recently he led Venrock’s private investments into Ascendis, Coherus, Edge Therapeutics, Tesaro and Zafgen, Previous investments where Anders served as a Board member include Adnexus Therapeutics (acquired by Bristol-Myers Squibb), Eyetech Pharmaceuticals (acquired by OSI Pharmaceuticals), PEAK Surgical (acquired by Medtronic), and The Medicines Company (NASDAQ: MDCO). In 2011, Anders was named to Forbes’ Midas List, which ranks the top venture capitalists in life sciences and technology.

Prior to Venrock, Anders held senior level positions in the medical, clinical and business operations of the pharmaceuticals division of Ciba-Geigy, and later as the portfolio manager of BB Biotech and CEO of Bellevue Asset Management. At Bellevue, Anders had responsibility for managing BB Biotech, an investment company with several billion dollar invested in public and private biotech companies. While at BB Biotech, Anders led numerous public and private investments and BB Biotech was the largest shareholder in companies such as Alexion (NASDAQ: ALXN), Medimmune (acquired by Astra Zeneca) and Aviron (acquired by Medimmune).

Anders earned his M.Sc. in Biotechnology Engineering from the Technical University of Denmark, his M.D. at the University of Copenhagen and an M.B.A. from INSEAD.

 

Active Companies

Edge Therapeutics

Ascendis Pharma

Coherus Biosciences

Impopharma

Zafgen

Intuity Medical

Mevion

QuatRx Pharma

Anacor Pharma

Alumni Companies

TESARO

Adnexus

PEAK Surgical

Alimera Sciences

Trubion Pharma